DBT Back

dihydrolipoamide branched chain transacylase E2

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of DBT
The branched-chain alpha-keto acid dehydrogenase complex (BCKD) is an inner-mitochondrial enzyme complex involved in the breakdown of the branched-chain amino acids isoleucine, leucine, and valine. The BCKD complex is thought to be composed of a core of 24 transacylase (E2) subunits, and associated decarboxylase (E1), dehydrogenase (E3), and regulatory subunits. This gene encodes the transacylase (E2) subunit. Mutations in this gene result in maple syrup urine disease, type 2. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.

Community Annotation of DBT Add / Edit DBT: Annotations

No community annotations yet for DBT.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

DBT is highly significantly mutated in
(none)
DBT is significantly mutated in
(none)
DBT is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for DBT